SWOG clinical trial number
CTSU/PR11
A Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer (START)
Closed
Phase
Abbreviated Title
Favorable Risk PCa, Surveillance vs Active Treatment, Ph III
Activated
07/15/2007
Closed
05/15/2011
Participants
CTSU
Research committees
Genitourinary Cancer
Symptom Control and Quality of Life
Treatment
Radiation Therapy
Surgery
Surveillance
Eligibility Criteria Expand/Collapse
The Southwest Oncology Group has endorsed this study through the Cancer Trials Support Unit (CTSU) of the National Cancer Institute.
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for information and registration procedures.
0.5 Cancer Control Credit
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for information and registration procedures.
0.5 Cancer Control Credit
Other Clinical Trials
SWOG Clinical Trial Number
S2205
ICE COMPRESS: Randomized Trial of Limb Cryocompression versus Continuous Compression Versus Low Cyclic Compression for the Prevention of Taxane-Induced Peripheral Neuroropathy
Research Committee(s)
Symptom Control and Quality of Life
Activated
03/16/2023
Accrual
22%
Open
Phase
SWOG Clinical Trial Number
S2010
A Randomized Phase III Trial Comparing Active Symptom Monitoring Plus Patient Education Versus Patient Education Alone To Improve Persistence with Endocrine Therapy in Young Women With Stage I-III Breast Cancer (ASPEN)
Research Committee(s)
Symptom Control and Quality of Life
Activated
01/17/2023
Accrual
64%
Open
Phase
SWOG Clinical Trial Number
EAQ202
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Research Committee(s)
Symptom Control and Quality of Life
Activated
10/28/2021
Open
Phase